PI
MED icon

PEAK6 Investments’s Medifast MED Stock Holding History

PEAK6 Investments’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-15,600
Closed -$1.05M – 4456
2023
Q4 		$1.05M Buy
15,600
+15,400
+7,700% +$1.07M ﹤0.01% 2055
2023
Q3 		$15K Buy
+200
New +$17.7K ﹤0.01% 3792
2022
Q4 		– Sell
-900
Closed -$98K – 4894
2022
Q3 		$98K Buy
+900
New +$129K ﹤0.01% 4099
2021
Q3 		– Sell
-9,600
Closed -$2.72M – 5508
2021
Q2 		$2.72M Buy
9,600
+5,000
+109% +$1.35M 0.01% 1594
2021
Q1 		$974K Sell
4,600
-28,600
-86% -$6.84M ﹤0.01% 2580
2020
Q4 		$6.52M Sell
33,200
-22,800
-41% -$4.03M 0.01% 907
2020
Q3 		$9.21M Buy
56,000
+38,500
+220% +$6.34M 0.02% 631
2020
Q2 		$2.43M Buy
+17,500
New +$1.61M 0.01% 1330
2019
Q4 		– Sell
-2,400
Closed -$249K – 3772
2019
Q3 		$249K Sell
2,400
-7,600
-76% -$817K ﹤0.01% 2758
2019
Q2 		$1.28M Buy
10,000
+9,600
+2,400% +$1.33M 0.01% 1621
2019
Q1 		$51K Buy
+400
New +$50.7K ﹤0.01% 3408

Other funds holding MED

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

PEAK6 Investments's MED Position: Q2 2024 in Review

PEAK6 Investments sold out of Medifast (MED) in Q2 2024, closing a stake of 82,437 shares — an estimated $3.16M sold.

PEAK6 Investments first reported a position in MED in Q1 2019 and held it in 12 quarters. The position peaked at $3.16M in Q1 2024. 158 funds tracked by Wall St. Rank hold MED as of Q2 2024.

  • PEAK6 Investments reported no remaining Medifast position as of Q2 2024 after selling out during the quarter.
  • PEAK6 Investments sold 82,437 Medifast shares in Q2 2024, an estimated $3.16M.
  • PEAK6 Investments first reported a position in Medifast in Q1 2019 and held it in 12 quarters.
  • PEAK6 Investments's Medifast position peaked at $3.16M in Q1 2024.
  • 158 funds tracked by Wall St. Rank held Medifast as of Q2 2024.

Based on PEAK6 Investments's 13F filing for Q2 2024, filed 14 Aug 2024.